TissUse reports progress made in collaboration with AstraZeneca to use Microphysiological Systems in the drug development process
TissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology. As part of the collaboration, the teams have explored the unmet need for a physiologically relevant human ex-vivo type 2 diabetes Mehr